Sodium salicylate inhibits macrophage TNF-α production and alters MAPK activation

Journal of Surgical Research

Volumn 84, Issue 2, 1999, Pages 143-149

  Vittimberga Jr , Frank J ^a   McDade, Theodore P ^a   Perugini, Richard A ^a   Callery, Mark P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Salicylates; Sepsis; Signal transduction

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SALICYLATE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; IMMUNOREGULATION; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; SEPSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 0344931905     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5630     Document Type: Article

References (37)

1. Morrison D., Ryan J. Endotoxin and disease mechanisms. Annu. Rev. Med. 38:1987;417.
2. Nathan C. Secretory products of macrophages. J. Clin. Invest. 79:1987;319.
3. van der Poll T., Lowry S. Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock. 3:1995;1.
4. Muller J., Ziegler-Heitbrock H., Baeuerle P. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology. 187:1993;233.
5. Weinstein S., Sanghera J., Lemke K., DeFranco A., Pelech S. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 267:1992;14955.
6. Geppert T., Whitehurst C., Thompson P., Beutler B. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the Ras/Raf-1/MEK/MAPK pathway. Mol. Med. 1:1994;93.
7. Reiman T., Bucher R., Hipskind R., Krautwald S., Lohmann-Matthes M.-L., Baccarini M. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. J. Immunol. 153:1994;5740.
8. Sanghera J., Weinstein S., Aluwalia M., Girn J., Pelech S. Activation of multiple proline directed kinases by bacterial lipopolysaccharide in murine macrophages. J. Immunol. 156:1996;4457.
9. Weinstein S., Gold M., DeFranco A. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc. Natl. Acad. Sci. USA. 88:1991;4148.
10. Seger R., Krebs E. The MAPK signaling cascade. FASEB J. 9:1995;726.
11. Schwenger P., Alpert D., Skolnick E., Vilcek J. Activation of p38 mitogen activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκBα phosphorylation and degradation. Mol. Cell. Biol. 18:1998;78.
12. Cano E., Mahadevan L. Parallel signal processing among mammalian MAPKs. Trends Biochem. 20:1995;117.
13. Wang X., Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science. 272:1996;1347.
14. Robinson M., Cobb M. Mitogen-activated protein kinase pathways. Curr. Opin. Cell. Biol. 9:1997;180.
15. Han J., Jiang Y., Li Z., Kravchenko V., Ulevitch R. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature. 386:1997;296.
16. Osnes L., Foss K., Joo G., Okkenhaug C., Westvik A.-B., Ovstebo R., Kierulf P. Acetasalicylic acid and sodium salicylate inhibit LPS-induced NF-κB/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis Factor alfa (sic) (TNF-α) in human monocytes. Thromb. Haemostasis. 76:1996;970.
17. Schwenger P., Bellosta P., Basilico C., Skolnik E., Vilcek J. Sodium salicylate induces apoptosis via p38 mitogen activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc. Natl. Acad. Sci. USA. 94:1997;2869.
18. Kopp E., Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 265:1994;956.
19. McDade T., Perugini R., Vittimberga F., Carrigan R., Callery M. Sodium salicylate inhibits tumor necrosis factor (TNF) induced IκB-α induced phosphorylation and degradation in human pancreatic cancer. Surg. Forum. 49:1998;438.
20. Schwenger P., Skolnik E., Vilcek J. Inhibition of tumor necrosis factor-induced p42/p44 mitogen activated protein kinase by sodium salicylate. J. Biol. Chem. 271:1996;8089.
21. Bowling W., Hafenrichter D., Flye M., Callery M. Endotoxin tolerance alters phospholipase C-γ1 and phosphtidylinsotitol-3′-kinase expression in peritoneal macrophages. J. Surg. Res. 58:1995;592.
22. Badger A., Bradbeer J., Votta B., Lee J., Adams J., Griswold D. Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279:1996;1453.
23. Lee J., Young P. Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukocyte Biol. 59:1996;152.
24. Chalsani N., Roman J., Jurado R. Systemic inflammatory response syndrome caused by chronic salicylate intoxication. South. Med. J. 89:1996;479.
25. Abramson S., Weissmann G. The mechanisms of action of nonsteroidal anti-inflammatory drugs. Arthritis Rheum. 32:1989;1.
26. Liou H., Baltimore D. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell. Biol. 5:1993;477.
27. Takashiba S., TE V. D., Shapira L., Amar S. Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor promoter. Infect. Immun. 63:1995;1529.
28. Lee J., Layson J., McDonnell P., Gallagher T., Kumar S., Green D., McNulty D., Blumenthal M., Heys J., Landvatter S., Strickland J., Young P. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739.
29. Kepka-Lenhart D., Chen L.-C., Morris S. Novel actions of aspirin and sodium salicylate: Discordant effects on nitric oxide synthesis and induction of nitric oxide synthase mRNA in a murine macrophage cell line. J. Leukocyte Biol. 59:1996;840.
30. Amin A., Vyas P., Attur M., Leszczynska-Piziak J., Patel I., Weissman G., Abramson S. The mode of action of aspirin-like drugs: Effect on inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 92:1995;7926.
31. Frantz B., O'Neill E. The effect of sodium salicylate and aspirin on NF-κB. Science. 1995;2017.
32. nd, Annual Meeting (abstract), 1998.
33. Weissmann G. The actions of NSAIDs. Hosp. Pract. 26:1991;60.
34. Mitchell J., Akarasereenont P., Thiemermann C., Flower R., Vane J. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA. 90:1993;11693.
35. Kunkel S., Spengler M., May M., Spengler R., Larrick J., Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263:1988;5380.
36. Renz H., Gong J., Schmidt A., Nain M., Gemsa D. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J. Immunol. 141:1988;2388.
37. Zhong W., Burke P., Drotar M., Chavali S. R., Forse R. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology. 84:1995;446.